FAST NEWS: Antengene Invests $36 Million in Drug Discovery Center
The latest: Biopharma company Antengene Corp. Ltd. (6996.HK) announced Monday it has entered into an agreement with a contractor to build a drug discovery and manufacturing center for antibody biologics in…
RELATED ARTICLES
-
Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
BeiGene heads for profit milestone after hemorrhaging cash
6160.HK ONC.US 688235.SHG
- As Covid drug cash dwindles, Vigonvita targets new remedies
-
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
